文献速递类风湿关节炎

超越表面——人类自身免疫性疾病中的自身反应性B细胞

Beyond the surface - Autoreactive B cells in human autoimmune diseases.
PubMed 文献 · Semin Arthritis Rheum · 2023-11-22

本文以类风湿关节炎及针对翻译后修饰抗原的B细胞反应为原型,采用组合式抗原特异性鉴定与多参数流式细胞术,在临床表型明确的队列(含疾病前期及长期无药缓解患者)中研究人类自身反应性B细胞的表型与功能特征。结果显示,针对翻译后修饰蛋白的自身反应性B细胞在确诊患者中表现为高度活化的效应记忆细胞并贯穿病程,可产生抵抗常规治疗的分泌细胞因子生发中心迁出细胞及表达归巢标志的迁移性浆母细胞;临床前期活化程度较低、迁移性浆母细胞较少。

要点

  • 针对翻译后修饰蛋白的自身反应性B细胞在确诊患者中为高度活化的效应记忆细胞并贯穿病程。
  • 活化产生抵抗常规治疗、分泌细胞因子的生发中心迁出细胞及表达归巢标志的迁移性浆母细胞。
  • 临床前期活化程度较低、迁移性浆母细胞较少;细胞对不同翻译后修饰交叉反应,B细胞受体可变域广泛糖基化。

核心结论

  • 对疾病特异性自身反应性B细胞进行免疫表型分析,可揭示反映疾病阶段与病程的人类自身免疫异质性特征,这些特征仅在抗原特异性细胞分析时显现。
  • 在类风湿关节炎中,呈现针对翻译后修饰抗原、来源于生发中心的B细胞自身反应性图景,表现为广泛交叉反应及可能依赖T细胞辅助。
  • 其他人类自身免疫病因疾病动力学不同,其特征可能不同,可能各自需要不同的(自身反应性)B细胞靶向策略。

研究设计与样本

  • 以类风湿关节炎及针对翻译后修饰抗原的B细胞反应为原型,研究人类疾病病程中自身反应性B细胞的表型与功能特征。
  • 采用组合式抗原特异性鉴定与多参数表型分析,通过常规流式细胞术与光谱流式细胞术检测。
  • 队列临床表型明确,包括疾病前期患者及达到长期无药缓解的患者。

主要发现

  • 针对翻译后修饰蛋白的自身反应性B细胞在确诊患者中表现为高度活化的效应记忆细胞,并在整个病程中维持该状态。
  • 活化产生分泌细胞因子的生发中心迁出细胞,这类细胞抵抗常规治疗;并产生表达归巢标志、可引导细胞至炎症部位的迁移性浆母细胞。
  • 在临床前风险期,活化程度较低,迁移性浆母细胞较少见。
  • 这些细胞对不同翻译后修饰呈交叉反应,其B细胞受体可变域广泛糖基化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The generation and persistence of autoreactive B and plasma cells is crucial to the pathogenesis of many human autoimmune diseases. Secreted autoantibodies frequently serve as biomarkers in clinical practice and, in some cases, function as pathogenic effector molecules. Nonetheless, the primary break of B cell tolerance against autoantigens, the triggers that maintain autoreactive B cell memory, and the phenotype that autoreactive B cells adopt during the disease course are poorly understood. OBJECTIVES: To study phenotype and functional characteristics of human autoreactive B cells in the course of human disease using rheumatoid arthritis and the B cell response against posttranslationally modified antigens as prototype. METHODS: Combinatorial, antigen-specific identification and multiparameter phenotyping of autoreactive B cells by conventional and spectral flow cytometry in cohorts with well-defined clinical phenotypes, including patients in the phase preceding disease and in those reaching long-term, drugfree remission. RESULTS: Autoreactive B cells against post-translationally modified proteins operate as remarkably activated effector memory cells in patients with established disease and maintain this state throughout the disease course. The activation generates cytokine-secreting germinal center emigrants that resist conventional therapy, and migratory plasmablasts expressing homing markers that can direct the cells to sites of inflammation. In the pre-clinical at-risk phase, the degree of activation is lower, and migratory plasmablasts are less frequent. The cells are cross-reactive to different posttranslational modifications and express B cell receptors that are extensively glycosylated in the variable domain. CONCLUSIONS: Immune phenotyping of disease-specific, autoreactive B cells reveals heterogeneous features of human autoimmunity that reflect disease stage and course and that are only revealed upon antigen-specific cellular analysis. In rheumatoid arthritis, the picture of germinal center-derived B cell autoreactivity against post-translationally modified antigens emerges that displays extensive cross-reactivity and a likely dependence on T cell help. Such features may be different for other human autoimmune diseases with different disease kinetics, which each may require different strategies for (autoreactive) B cell targeting.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Scherer HU. Beyond the surface - Autoreactive B cells in human autoimmune diseases. Semin Arthritis Rheum. 2023. PMID: 38008707. doi:10.1016/j.semarthrit.2023.152315

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。